Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 13, 1999

View Archived Issues

ID Biomedical initiates phase I trials of GAS vaccine

Ixion Biotechnology awarded NIH grant for type I diabetes research

Licensing opportunity from NIH: gene therapy for chronic or persistent pain

Licensing opportunity from NIH: cyanovirin N-based topical microbicides active against HIV

Nonpeptide modulators of GnRH release patented by Alanex

New triazole antifungal agents developed at Roche

Selective ligands for 5-ht6 receptors from Roche useful for CNS disorders

Pfizer's new macrolides described in recent patent literature

HMR prepares potassium channel blockers for arrhythmias, etc.

Emory U. develops metal chelates for renal imaging with advantageous properties

Two new photoactivatable, biotin-labeled verapamil analogues useful for studies on P-170

Positive phase I/II reported for Nuvance at European meeting

Clinical results presented at ICAAC demonstrate equivalence of Twinrix to two monovalent vaccines

Viral load significantly reduced by addition of T-20 in heavily pretreated HIV-infected patients

Herpes simplex L.E.A.P.S. vaccine is protective in animal models

Pleconaril now shown to be effective in adolescents and adults with enteroviral meningitis

DHA: a new treatment for CF on the horizon?

SU-5416: promising phase I findings presented at ICAAC; update on clinical status

PDE3 inhibitor olprinone is an effective bronchodilator in asthma patients

Glaxo Wellcome receives approval in Germany for Flixotide in COPD

News from ERS: tiotropium prevents methacholine-induced bronchoconstriction in asthmatics

Resistance profile of DAPD elucidated in vitro

Panel recommends Pfizer's Zoloft for Rx of posttraumatic stress disorder

ImClone Systems initiates enrollment in phase II C225/CPT-11 trial

Preclinical, early clinical results indicate good efficacy and safety of D-4418

DuPont acquires ImaRx

Antimetastatic activity demonstrated for new MAb in breast cancer-bearing mice

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...